🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals administering substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Material Removal

Based on the social media company, the service has taken down problematic material and banned associated keywords and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.

After minutes of entering one community, a vendor shared contact information, where most purchases take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts display dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly serious medical dangers”.